| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/13/2008 | CN101124226A 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 02/13/2008 | CN101124225A Metabolites of certain [1,4]diazepino[6,7,1-IJ]quinoline derivatives and methods of preparation and use thereof |
| 02/13/2008 | CN101121715A 菲咯啉衍生物化合物 Phenanthroline derivative compounds |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/12/2008 | US7329751 Process for the preparation of clopidogrel |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329677 2-[3-(4-Methoxypyridin-2-yl)prop-2-yl]-3H-imidazo[4,5-b]pyridine hydrochloride; transcriptional activation of the iNOS-promoter, tissue and organ damage, cytotoxicity reduction |
| 02/12/2008 | US7329673 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers |
| 02/12/2008 | US7329668 For therapy of inflammatory diseases, immune diseases, and cancer |
| 02/12/2008 | US7329667 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor |
| 02/12/2008 | US7329666 Antitumor agents |
| 02/12/2008 | US7329659 Substituted-1-phthalazinamines as vr-1 antagonists |
| 02/12/2008 | US7329653 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 02/12/2008 | CA2315261C Oral pharmaceutical extended release dosage form |
| 02/12/2008 | CA2227695C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 02/07/2008 | WO2008016700A2 N-oxide compounds for therapeutics uses |
| 02/07/2008 | WO2008016661A2 Morpholino compounds for treating inflammatory and demyelinating diseases and cancers |
| 02/07/2008 | WO2008016648A2 Certain chemical entities, compositions and methods |
| 02/07/2008 | WO2008016547A2 Aurora kinase inhibitors from an encoded small molecule library |
| 02/07/2008 | WO2008016184A1 Alpha-carboline derivatives and methods for preparation thereof |
| 02/07/2008 | WO2008016166A1 Fused heterocyclic compound and organic light emitting device |
| 02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
| 02/07/2008 | WO2008016002A1 AMYLOID β PRODUCTION REGULATOR CONTAINING PROTON PUMP INHIBITOR |
| 02/07/2008 | WO2008015516A1 Fused tricyclic heterocycles for the treatment of schizophrenia |
| 02/07/2008 | WO2008015437A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 02/07/2008 | WO2008015416A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 02/07/2008 | WO2008015196A1 5-,7-bis-substituted imidazo[1,2-a]pyridines |
| 02/07/2008 | WO2008014888A2 Imino-imidazo-pyridine derivatives having antithrombotic activity |
| 02/07/2008 | WO2007109596A3 Heteroaryl dihydroindolones as kinase inhibitors |
| 02/07/2008 | WO2007103308A3 Heterobicyclic pyrazole compounds and methods of use |
| 02/07/2008 | WO2007050050A3 Thiazolyl mglur5 antagonists and methods for their use |
| 02/07/2008 | WO2006105304A8 Phenyl and pyridyl lta4h modulators |
| 02/07/2008 | US20080033175 Process for preparation of 4-amino-3-quinolinecarbonitriles |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033006 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors |
| 02/07/2008 | US20080033004 Synthesis of grossularines-1 and analogs thereof and method of use |
| 02/07/2008 | US20080033001 Derivatives of Variolin B |
| 02/07/2008 | US20080032997 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032991 2, 8-disubstituted Naphthyridine Derivatives |
| 02/07/2008 | US20080032985 4-Substituted Quinoline Derivatives, Method and Intermediates for Their Preparation and Pharmaceutical Compositions Containing Them |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/07/2008 | US20080032974 Compounds and therapeutical use thereof |
| 02/07/2008 | US20080032973 2-Quinazolinone compounds and methods of use |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032960 PI3 kinase antagonists |
| 02/07/2008 | DE102006036023A1 Imino-imidazo-pyridinderivate mit antithrombotischer Aktivität Imino-imidazo-pyridine derivatives with antithrombotic activity |
| 02/07/2008 | CA2663332A1 Iminoimidazopyridine derivatives having antithrombotic activity |
| 02/07/2008 | CA2659539A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 02/06/2008 | EP1845981A4 Synthesis of sodium narcistatin and related compounds |
| 02/06/2008 | CN101119996A Chemical compouns |
| 02/06/2008 | CN101119995A Non steroidal glucocorticoid receptor modulators |
| 02/06/2008 | CN101119987A Novel compounds |
| 02/06/2008 | CN101119968A Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 02/06/2008 | CN100366616C Novel bicyclic inhibitors of hormone sensitive lipase |
| 02/06/2008 | CN100366254C Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326788 Quinolinone derivatives as inhibitors of c-fms kinase |
| 02/05/2008 | US7326784 Intermediates for the preparation of tricyclic dihydropyrano-imidazo-pyridines derivatives |
| 02/05/2008 | US7326718 8-Substituted imidazopyridines |
| 02/05/2008 | US7326716 Treatment of inflammatory bowel disease |
| 02/05/2008 | US7326712 Substituted tricyclic compounds as protein kinase inhibitors |
| 02/05/2008 | US7326711 Antiproliferative agents for humans, animals |
| 02/05/2008 | US7326709 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder |
| 02/05/2008 | US7326708 Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326702 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example |
| 02/05/2008 | US7326475 Material for organic electroluminescent device, organic electroluminescent device, illuminating device and display |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2383315C New derivatives of pyrimidin-4-ones, the process for the preparation thereof and the pharmaceutical compounds that contain them |
| 02/05/2008 | CA2289206C Efficient enantioselective addition reaction using an organozinc reagent |
| 02/05/2008 | CA2205406C Novel benzyl pyrimidines |
| 01/31/2008 | WO2008014291A2 Compounds and compositions as hedgehog signaling pathway modulators |
| 01/31/2008 | WO2008014236A1 Dimeric iap inhibitors |
| 01/31/2008 | WO2008012782A2 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 01/31/2008 | WO2008012635A2 Amine derivatives useful as anticancer agents |
| 01/31/2008 | WO2008012623A1 Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 01/31/2008 | WO2008012622A2 Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 01/31/2008 | WO2007109810A3 Methods for the preparation of imidazole-containing compounds |
| 01/31/2008 | WO2006107753A3 Pyrazolopyridines and analogs thereof |
| 01/31/2008 | WO2006092722A8 Peptidomimetic compounds and preparation of biologically active derivatives |
| 01/31/2008 | US20080027224 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 01/31/2008 | US20080027093 Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/31/2008 | US20080027092 1-Acetic Acid-Indole, -Indazole and -Benzimidazole Derivatives Useful for the Treatment of Respiratory Disorders |
| 01/31/2008 | US20080027085 2-(Pyridin-2-Yl)-Pyrimidines and Their Use for Controlling Harmful Fungi |
| 01/31/2008 | US20080027069 Quinazoline compounds |
| 01/31/2008 | US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio) |
| 01/31/2008 | US20080027040 Oxazolidinone-Quinolone Hybrid Antibiotics |
| 01/31/2008 | CA2658782A1 Compounds and compositions as hedgehog pathway modulators |
| 01/31/2008 | CA2658624A1 Pyridazine and pyrrole compounds, processes for obtaining them and applications thereof |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1881983A1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 01/30/2008 | EP1881982A1 Imidazolone phenylalanine derivatives as vla-4 antagonists |
| 01/30/2008 | EP1881981A1 4, 6-diamino-[1,7] naphthyridine-3-carbonitrile inhibitors of tpl2 kinase and methods of making and using the same |
| 01/30/2008 | EP1881827A1 Fused thiazole derivatives as kinase inhibitors |
| 01/30/2008 | EP1881825A2 Hiv integrase inhibitors |
| 01/30/2008 | EP1521757B1 tricyclic spiropiperidines or spiropyrrolidines |
| 01/30/2008 | CN101115753A Bridged ring nk1 antagonists |
| 01/30/2008 | CN101115752A 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 01/30/2008 | CN101115484A Tadalafil crystal forms and processes for preparing them |